Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
The leaves of Chenopodium ambrosioides L. [Chenopodiaceae] ('mastruz') have been indicated for the treatment of several diseases, among which the cancer. There are no results focusing the effect of C. ambrosioides treatment on tumor development in vivo. The aim of this study was to investigate the effect of treatment with C. ambrosioides on Ehrlich tumor development. Swiss mice were treated by intraperitoneal route (i.p.) with hydroalcoholic extract from leaves of C. ambrosioides (5 mg/kg) or with PBS (control group) 48 h before or 48 h later the Ehrlich tumor implantation. The tumor cells were implanted on the left footpad (solid tumor) or in the peritoneal cavity (ascitic tumor). To determine the solid tumor growth, footpad was measured each 2 days until the fourteenth day, when the feet were weighed. Ascitic tumor development was evaluated after 8 days of tumor implantation by quantification of the ascitic fluid volume and tumor cell number. The i.p. administration of C. ambrosioides extract before or after the tumor implantation significantly inhibited the solid and ascitic Ehrlich tumor forms. This inhibition was observed in ascitic tumor cell number, in the ascitic volume, in the tumor-bearing foot size and foot weight when compared to control mice. The treatments also increased the survival of tumor-bearing mice. In conclusion, C. ambrosioides has a potent anti-tumoral effect which was evident with a small dose and even when the treatment was given two days after the tumor implantation. This effect is probably related with anti-oxidant properties of C. ambrosioides.
Nascimento
Flávia R F
FR
Laboratório de Imunofisiologia, Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, Av. dos Portugueses, s/n, Campus do Bacanga, São Luís, MA, Brazil. nascimentofrf@yahoo.com.br
Cruz
Gustavo V B
GV
Pereira
Paulo Vitor S
PV
Maciel
Márcia C G
MC
Silva
Lucilene A
LA
Azevedo
Ana Paula S
AP
Barroqueiro
Elizabeth S B
ES
Guerra
Rosane N M
RN
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D027464:Chenopodium ambrosioides / Q000737:chemistry*; D004354:Drug Screening Assays, Antitumor; D007274:Injections, Intraperitoneal; D008136:Longevity / Q000187:drug effects; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D018515:Plant Leaves / Q000737:chemistry; D015996:Survival Rate
D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts